Viewing nowRosuvastatin Calcium 20 mg Tablets
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201400419 · Approved 2014.01.29 · Insurance code 651204040
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medicine is used primarily as an adjunct therapy for patients with primary hypercholesterolemia and mixed dyslipidemia, who find it difficult to control their condition through diet and exercise alone. It can also be used as an adjunct to diet or other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. It helps reduce the total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It also serves as an adjunct to diet for patients with primary dysbetalipoproteinemia. Furthermore, it improves cardiovascular health by reducing the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 years old and women over 60 years old with elevated high-sensitivity C-reactive protein and cardiovascular risk factors.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased up to a maximum of 20 mg daily. 2. Older adults: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this drug to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 5. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this drug is contraindicated in some of these patients.
This medication should not be administered to certain patients. For example, it should not be used in patients who are allergic to any of the ingredients, have severe liver impairment, have muscle disorders, or have severe renal impairment. Additionally, women who are pregnant or breastfeeding, as well as fertile women not using effective contraception, should not take this medication. This medication can cause muscle problems, so special caution is needed for patients with a history of muscle disorders, moderate to severe renal impairment, hypothyroidism, alcoholics, and those taking certain concurrent medications. This medication contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. This medication can affect liver health, so patients with a history of liver disease or who excessively consume alcohol should regularly undergo liver function tests before and during treatment. If muscle pain, weakness, or cramps occur, contact a doctor immediately for necessary tests. Especially at high doses, kidney function tests might also be necessary. Rarely, side effects such as headaches, dizziness, dyspepsia, itching, rash, muscle pain, fatigue, pallor, numbness, and abnormal sensations may occur while taking this medication. Serious reactions like rash, liver damage, or muscle damage can sometimes occur, so if these symptoms appear, consult medical professionals immediately. This medication may interact with other drugs, so if you are taking other medications, you must inform your healthcare provider. Be especially cautious when taken concurrently with certain antiviral medications, immunosuppressants, select antibiotics, and fibrate drugs, as it may increase the risk of muscle damage. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraceptive methods. In case of overdose, there is no specific antidote, so treatment should be based on symptoms, and liver and muscle function tests are necessary. Caution should be exercised as dizziness may occur while driving or operating machinery. Lastly, this medication may show higher systemic concentrations in Asians, so dosage adjustment may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, difficulty breathing, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom-induced drug reaction syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its effectiveness.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 100 tablets/box[(10 tablets/PTP*10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.